Close Menu

NEW YORK — Advanced Biological Laboratories said on Tuesday that it has received CE-IVD marking for its DeepChek sequencing-based assays for HIV genotyping and drug resistance testing.

According to Luxembourg-based ABL, the DeepChek-HIV assays cover the protease/reverse transcriptase and the integrase regions of the virus, respectively, and are intended for use with input RNA extracted from plasma, serum, or whole blood samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.